887 followers
1,051 followers
Venetoclax: Targeting BCL2 in Hematological Cancers. https://t.co/i2Z0mIll1J https://t.co/nTUmbCWmo1
Small Molecules in Hematology
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Imatinib Mesylate
-
Altmetric BadgeChapter 2 Dasatinib
-
Altmetric BadgeChapter 3 Nilotinib
-
Altmetric BadgeChapter 4 Bosutinib: A Potent Second-Generation Tyrosine Kinase Inhibitor
-
Altmetric BadgeChapter 5 Ponatinib: A Third-Generation Inhibitor for the Treatment of CML
-
Altmetric BadgeChapter 6 Ruxolitinib
-
Altmetric BadgeChapter 7 Ibrutinib
-
Altmetric BadgeChapter 8 Pomalidomide
-
Altmetric BadgeChapter 9 Enasidenib
-
Altmetric BadgeChapter 10 Midostaurin: A Multiple Tyrosine Kinases Inhibitor in Acute Myeloid Leukemia and Systemic Mastocytosis
-
Altmetric BadgeChapter 11 Venetoclax: Targeting BCL2 in Hematological Cancers
-
Altmetric BadgeChapter 12 Idelalisib
-
Altmetric BadgeChapter 13 Carfilzomib
-
Altmetric BadgeChapter 14 Acalabrutinib, A Second-Generation Bruton’s Tyrosine Kinase Inhibitor
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Among the highest-scoring outputs from this source (#16 of 173)
-
High Attention Score compared to outputs of the same age (88th percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Citations
- dimensions_citation
- 10 Dimensions
Readers on
- mendeley
- 47 Mendeley